Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation

Prostate

Volumn 47, Issue 4, 2001, Pages 285-292

  Juarranz, Maria G ^a   Bodega, Guillermo ^a   Prieto, Juan C ^a   Guijarro, Luis G ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

CAMP; Inositol phosphate; PACAP 27; Proliferation; Prostate; VIP

Indexed keywords

BUCLADESINE; CYCLIC AMP; CYTOKERATIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; INOSITOL PHOSPHATE; THYMIDINE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; EPITHELIUM CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; INOSITOL PHOSPHATES; MALE; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROSTATE; RATS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0035370176     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1073     Document Type: Article

References (36)

1. Peptidergic innervation of the human prostate, seminal vesicle and vas deferens
2. Neuroendocrine peptides in the prostate
3. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) gene by spermatogenic cells
4. Pituitary adenylate cyclase-activating polypeptide can regulate testicular cell protein synthesis in vitro
5. Pitutary adenylate cyclase-activating polypeptide (PACAP) can cross the vascular component of the blood-testis barrier in the mouse
6. Vasoactive intestinal polypepfide. Biologic role in health and disease
7. Effects of vasoactive intestinal peptide on canine prostatic contraction and secretion
8. Requirement of innervation for maintenance of structural and functional integrity in the rat prostate
9. Ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate
10. The effect of streptozotocin diabetes on vasoactive intestinal peptide receptor/effector system in membranes from rat ventral prostate
11. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment
12. Differential effects of peptide hormones, bombesin, vasoactive intestinal peptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
13. Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP prostate cancer cells
14. Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP and carbachol: Role in prostatic proliferation
15. Type I vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation
16. International Union of Pharmacology. XVIII Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
17. 1 receptors: Evidence for multiple receptor states
18. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin
19. 1 subtype is predominant in rat prostate membranes
20. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in human benign hyperplastic prostate
21. 1) receptor in human benign hyperplastic prostate
22. Radioimmunoassay techniques for cyclic nucleotides
23. Separation of mature rat ventral prostate epithelial and fibroblast cells
24. Androgen independent epithelial cells of rat ventral prostate
25. The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostate
26. Lindane affects phosphoinositide turnover through a different mechanism of the phosphatidylinositol synthesis inhibition in rat renal proximal tubule cell culture
27. Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines
28. PACAP (6-38) inhibits the growth of prostate cancer cells
29. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines
30. The primary culture of rat prostate basal cells
31. Cytokeratin and vimentin intermediate filament proteins in benign and neoplastic prostatic epithelium
32. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor
33. Comitogenic effects of vasoactive intestinal polypeptide on rat hepatocytes
34. Direct effects of cutaneous neuropeptides on adenylate cyclase activity and proliferation in a keratinocyte cell line: Stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors
35. 2+ transients
36. Androgen-independent induction of prostate-specific antigen gene expression via cross talk between the androgen receptor and protein kinase A signal transduction pathways